Literature DB >> 11579070

Phenylethylamine, a possible link to the antidepressant effects of exercise?

A Szabo1, E Billett, J Turner.   

Abstract

OBJECTIVES: To determine in this pilot study whether aerobic exercise affects phenylacetic acid concentration in the urine.
METHODS: Twenty healthy men provided 24 hour urine samples on two consecutive days for the determination of phenylacetic acid levels. Before and during day 1, subjects refrained from physical activity; on day 2 subjects ran on a treadmill at 70% of their maximal heart rate reserve (MHRR) for 30 minutes.
RESULTS: The 24 hour mean urinary concentration of phenylacetic acid was increased by 77% after exercise.
CONCLUSION: As phenylacetic acid concentration in urine reflects phenylethylamine level, which is known to have antidepressant effects, phenylethylamine may be linked to the therapeutic effects of physical exercise on depression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11579070      PMCID: PMC1724404          DOI: 10.1136/bjsm.35.5.342

Source DB:  PubMed          Journal:  Br J Sports Med        ISSN: 0306-3674            Impact factor:   13.800


  4 in total

Review 1.  Acute aerobic exercise and affect: current status, problems and prospects regarding dose-response.

Authors:  P Ekkekakis; S J Petruzzello
Journal:  Sports Med       Date:  1999-11       Impact factor: 11.136

2.  Gas-liquid chromatographic determination of total phenylacetic acid in urine.

Authors:  F Gusovsky; H Sabelli; J Fawcett; J Edwards; J I Javaid
Journal:  Anal Biochem       Date:  1984-01       Impact factor: 3.365

3.  Sustained antidepressant effect of PEA replacement.

Authors:  H Sabelli; P Fink; J Fawcett; C Tom
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1996       Impact factor: 2.198

Review 4.  Phenylethylamine modulation of affect: therapeutic and diagnostic implications.

Authors:  H C Sabelli; J I Javaid
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1995       Impact factor: 2.198

  4 in total
  6 in total

Review 1.  Exercise and bipolar disorder: a review of neurobiological mediators.

Authors:  Mohammad T Alsuwaidan; Aaron Kucyi; Candy W Y Law; Roger S McIntyre
Journal:  Neuromolecular Med       Date:  2009       Impact factor: 3.843

2.  Cardiorespiratory Fitness and All-Cause Mortality in Men With Emotional Distress.

Authors:  Xuemei Sui; John Ott; Katie Becofsky; Carl J Lavie; Linda Ernstsen; Jiajia Zhang; Steven N Blair
Journal:  Mayo Clin Proc       Date:  2017-05-09       Impact factor: 7.616

3.  Depressed Adolescents Treated with Exercise (DATE): A pilot randomized controlled trial to test feasibility and establish preliminary effect sizes.

Authors:  Carroll W Hughes; Shauna Barnes; Conrad Barnes; Laura F Defina; Paul Nakonezny; Graham J Emslie
Journal:  Ment Health Phys Act       Date:  2013-06

4.  Effect of Supplementation with Olive Leaf Extract Enriched with Oleuropein on the Metabolome and Redox Status of Athletes' Blood and Urine-A Metabolomic Approach.

Authors:  Nikolaos Lemonakis; Vassilis Mougios; Maria Halabalaki; Ioanna Dagla; Anthony Tsarbopoulos; Alexios-Leandros Skaltsounis; Evagelos Gikas
Journal:  Metabolites       Date:  2022-02-20

5.  Altered metabolome and microbiome features provide clues in understanding irritable bowel syndrome and depression comorbidity.

Authors:  Lijuan Han; Ling Zhao; Yong Zhou; Chao Yang; Teng Xiong; Lin Lu; Yusheng Deng; Wen Luo; Yang Chen; Qinwei Qiu; Xiaoxiao Shang; Li Huang; Zongchao Mo; Shaogang Huang; Suiping Huang; Zhi Liu; Wei Yang; Lixiang Zhai; Ziwan Ning; Chengyuan Lin; Tao Huang; Chungwah Cheng; Linda L D Zhong; Shuaicheng Li; Zhaoxiang Bian; Xiaodong Fang
Journal:  ISME J       Date:  2021-11-08       Impact factor: 10.302

6.  Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine.

Authors:  Xiaoqun Zhang; Ioannis Mantas; Alexandra Alvarsson; Takashi Yoshitake; Mohammadreza Shariatgorji; Marcela Pereira; Anna Nilsson; Jan Kehr; Per E Andrén; Mark J Millan; Karima Chergui; Per Svenningsson
Journal:  Front Pharmacol       Date:  2018-03-01       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.